1. 1) The Public Relations Office of the Government of Japan: 〈https://www.gov-online.go.jp/useful/article/201806/3.html#section5〉, cited 23 May, 2019.
2. 2) Executive Office of the President of the United States of America, “National Drug Control Strategy 2016,” Office of National Drug Control Strategy Policy, Washington, D.C., 2016.
3. 3) Akutsu M., Yakugaku Zasshi, 139, 693-697 (2019).
4. 4) Brunton L. L., Hial-Dandan R., Knollmann B. C., “Goodman and Gilman's The Pharmacological Basis of Therapeutics,” 13th ed., Pergamon Press, New York, 2018, pp. 440-441.
5. 5) Ohlsson A., Lindgren, J. E., Wahlen A., Agurell S., Hollister L. E., Gillespie H. K., Clin. Pharmacol. Ther., 28, 409-416 (1980).